Colm Murphy

Colm is a partner in Goodwin’s Life Sciences group and a European Patent Attorney, European Patent Litigator and Chartered Patent Attorney with a practice covering a broad range of IP matters in the life sciences arena. He has over 25 years' experience advising clients in relation to biochemical, pharmaceutical and medical device patents.

Colm's practice includes drafting and prosecuting patent applications to EPO Oppositions and Appeals; freedom-to-operate clearances; as well advising on IP portfolio/ risk management strategies; and IP exploitation. Known for his strategic approach, Colm has particular experience building strategic IP portfolios for life sciences companies in line with their commercial objectives. In addition he has advised on the IP related aspects of numerous investment transactions/funding rounds both from the company and investment side.

Colm also has experience advising clients in contentious matters including Opposition and Appeals at the European Patent Office. He acts in this area as European counsel for a global gene sequencing company and has successfully defended and invalidated many European patents on their behalf.

He is independently recognised as a leading practitioner. The Legal 500 states that "Colm Murphy is highlighted for his excellent advice and knowledge" while UK Chambers & Partners has ranked him in Band 1 for patent attorneys. Colm is also recognised as an IP Star by Managing IP and by IAM Patent 1000 as a leading patent professional.

• European Patent Office
• UK Intellectual Property Office
• Representative before Unified Patent Court

• The Legal 500 UK: Brand Management, Intellectual Property, and Pharmaceuticals and Biotechnology
• Managing Intellectual Property: IP Star
• Lexology Index: IP – Patent Agents & Attorneys